tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ANIP Stock Latest News

ANI Pharmaceuticals Completes Mandatory Conversion of Preferred Shares
Company AnnouncementsANI Pharmaceuticals Completes Mandatory Conversion of Preferred Shares
23h ago
8K
ANIP
Strong Growth Potential for ANI Pharmaceuticals Driven by Cortrophin Gel and Strategic Expansion
PremiumRatings
Strong Growth Potential for ANI Pharmaceuticals Driven by Cortrophin Gel and Strategic Expansion
3d ago
ANIP
ANI Pharmaceuticals price target raised to $115 from $95 at JPMorgan
PremiumThe Fly
ANI Pharmaceuticals price target raised to $115 from $95 at JPMorgan
3d ago
ANIP
ANI Pharmaceuticals price target raised to $121 from $93 at H.C. Wainwright
PremiumThe Fly
ANI Pharmaceuticals price target raised to $121 from $93 at H.C. Wainwright
10d ago
ANIP
ANI Pharmaceuticals price target raised to $114 from $86 at Guggenheim
PremiumThe Fly
ANI Pharmaceuticals price target raised to $114 from $86 at Guggenheim
19d ago
ANIP
ANI Pharmaceuticals Highlights Commercialization Focus Amid Challenges
PremiumCompany AnnouncementsANI Pharmaceuticals Highlights Commercialization Focus Amid Challenges
19d ago
8K
ANIP
ANI Pharmaceuticals’ Record Earnings and Optimistic Outlook
Premium
Company Announcements
ANI Pharmaceuticals’ Record Earnings and Optimistic Outlook
2M ago
ANIP
ANI Pharmaceuticals price target raised to $77 from $65 at Truist
Premium
The Fly
ANI Pharmaceuticals price target raised to $77 from $65 at Truist
2M ago
ANIP
ANI Pharmaceuticals Reports Record Growth in Q2 2025
PremiumCompany Announcements
ANI Pharmaceuticals Reports Record Growth in Q2 2025
2M ago
ANIP
ANI Pharmaceuticals price target raised to $93 from $84 at H.C. Wainwright
PremiumThe Fly
ANI Pharmaceuticals price target raised to $93 from $84 at H.C. Wainwright
2M ago
ANIP
ANI Pharmaceuticals price target raised to $94 from $80 at Piper Sandler
PremiumThe Fly
ANI Pharmaceuticals price target raised to $94 from $80 at Piper Sandler
2M ago
ANIP
Morning Movers: Under Armour sinks following second quarter earnings
PremiumThe Fly
Morning Movers: Under Armour sinks following second quarter earnings
2M ago
UA
AMR
ANI Pharmaceuticals reports Q2 adjusted EPS $1.80, consensus $1.42
PremiumThe FlyANI Pharmaceuticals reports Q2 adjusted EPS $1.80, consensus $1.42
2M ago
ANIP
ANI Pharmaceuticals raises FY25 adj. EPS view to $6.98-$7.35 from $6.27-$6.62
Premium
The Fly
ANI Pharmaceuticals raises FY25 adj. EPS view to $6.98-$7.35 from $6.27-$6.62
2M ago
ANIP
Is ANIP a Buy, Before Earnings?
Premium
Pre-Earnings
Is ANIP a Buy, Before Earnings?
2M ago
ANIP
Positive Outlook on ANI Pharmaceuticals Despite Legal Setback: Buy Rating Reaffirmed
PremiumRatings
Positive Outlook on ANI Pharmaceuticals Despite Legal Setback: Buy Rating Reaffirmed
2M ago
ANIP
ANI Pharmaceuticals to Challenge Court Verdict
PremiumCompany Announcements
ANI Pharmaceuticals to Challenge Court Verdict
2M ago
8K
ANIP
CG Oncology announces Delaware Superior Court ruling in its favor
PremiumThe Fly
CG Oncology announces Delaware Superior Court ruling in its favor
2M ago
ANIP
CGON
Optimistic Growth Potential for ANI Pharmaceuticals Despite Challenges in DME Treatment
PremiumRatings
Optimistic Growth Potential for ANI Pharmaceuticals Despite Challenges in DME Treatment
2M ago
ANIP
ANI Pharmaceuticals Reveals NEW DAY Study Results
PremiumCompany AnnouncementsANI Pharmaceuticals Reveals NEW DAY Study Results
2M ago
8K
ANIP
Optimistic Buy Rating for ANI Pharmaceuticals Despite Clinical Trial Challenges
Premium
Ratings
Optimistic Buy Rating for ANI Pharmaceuticals Despite Clinical Trial Challenges
2M ago
ANIP
ANI Pharmaceuticals Reports on NEW DAY Clinical Trial Results
Premium
Company Announcements
ANI Pharmaceuticals Reports on NEW DAY Clinical Trial Results
2M ago
8K
ANIP

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >